Izinzuzo zezeMpilo, Ukusetshenziswa, nokuningi
I-hip hip isithelo esivela eziqhakazweni zezitshalo zasendle zasendle. Isithako esivamile ematheni we-herbal, i-hip rose ibuye itholakale ekwakhekeni kanye nefomu eliyimpuphu. I-hip hip iqukethe ama-antioxidants amaningi, kuhlanganise ne- vitamin C , i-vitamin E, i-beta-carotene ne- lycopene .
Ukusetshenziswa kwe-Rose Hip
Eminye imithi, i-hip rose ifakwe njengendlela yokwelapha yemvelo ngezinkinga ezihlukahlukene zempilo, kubandakanya:
- i-arthritis
- ukuhlungu obusemhlane
- isifo sikashukela
- ama-gallstones
- i-gout
- sciatica
- izilonda
- ukutheleleka kwe-urinary tract
Ngaphezu kwalokho, i-hip iphakanyiswe ukuthi iqinise isimiso somzimba sokuzivikela , ivuselele ukujikeleza, inciphise ukuvuvukala nokusiza ukuvimbela isifo senhliziyo .
Izinzuzo zezempilo zikaRose Hip
Nakuba ucwaningo ngemiphumela yezempilo lwe-rose hip lincane, kunobunye ubufakazi bokuthi i-hip ivukile inganikeza izinzuzo ezithile. Nakhu ukubuka okutholwe okutadisha okuyinhloko:
1) I-arthritis
Ucwaningo oluthile lubonisa ukuthi i-hip hip ingasiza ukuphatha i- osteoarthritis ne- rheumatoid arthritis .
Esifundweni sika-2005 e- Scandinavian Journal of Rheumatology , abacwaningi bathola ukuthi i-hip yama-rose ingahlinzeka ngosizo lwe-osteoarthritis. Ukuze kuhlolwe, iziguli ezingu-94 ezine-osteoarthritis we-hip noma amadolo zaziphathwa nge-rose hip noma i-placebo enyangeni ezintathu. Ngokuphela kwesifundo, amalungu eqembu le-hip rose ayebhekene nokuncipha okukhulu kakhulu ebuhlungu nasekusebenziseni imithi yobuhlungu kunabo abasebandleni le-placebo.
Okwamanje, isifundo se- Phytomedicine ngonyaka ka-2010 sathola ukuthi iziguli ze-rheumatoid arthritis zingazuza ngokungeza i-hip powder ekunakekeleni kwabo okujwayelekile. Lolu cwaningo lwaluhilela iziguli ezingama-89 eziphathelene nokuhlukunyezwa kwesifo sofuba, ngasinye esasiphathwa nge-rose ye-hip supplement noma i-placebo izinyanga eziyisithupha. Amalungu eqembu le-hip rose aphela ekuboniseni ukuthuthukiswa okukhulu kwezinye izinyathelo zokusebenza ngokomzimba, nakuba kwakungekho umehluko omkhulu emazingeni obuhlungu phakathi kwamaqembu amabili.
2) Izifo Zenhliziyo
I-hip hip ingasiza ekuvimbeleni isifo senhliziyo kubantu abakhulu kakhulu, ngokusho kwesifundo esincane e- European Journal of Clinical Nutrition . Ukuze kuhlolwe, abantu abangu-31 abadliwayo badla isiphuzo equkethe noma i-rose hip powder noma i-placebo nsuku zonke amasonto ayisithupha. Ngokuphela kokucwaninga, amalungu eqembu lama-rose hip abonise ukuthuthukiswa okukhulu kwezici eziningana zempilo yengqondo (njengokucindezela kwe-systolic ephakeme ne- cholesterol ephezulu ) kuqhathaniswa nalabo abaseqembu le-placebo. Kodwa-ke, ezinye izici eziyingozi (njenge-diastolic ephakeme yegazi kanye namazinga okwanda kwesibindi) azifani phakathi kwamaqembu amabili.
3) Isifo sikashukela
Ucwaningo lokuqala lubonisa ukuthi i-hip hip ingasiza ekulwa nesifo sikashukela. Esifundweni sika-2011 ku- American Journal of Physiology: I-Endocrinology ne-Metabolism , ososayensi bathola ukuthi amaviki angu-20 okwelapha nge-hip rose hip basiza ukuvimbela ukuthuthukiswa kwesifo sikashukela emagundwini okondla ukudla okunamafutha aphezulu. I-hip i-rose yavela futhi ukusiza ukulawula amazinga kashukela egazi futhi igcine i-cholesterol isheke. Kodwa-ke, kusheshe ukutshela ukuthi i-rose hip ingakwazi yini ukusiza ukuvimbela isifo sikashukela kubantu.
Bheka ezinye iziMpilo Zesifo Sikashukela .
Amapulangwe
Ngenkathi i-hip rose ibizwa ngokuthi iphephile, ukuthatha izithako ze-hip ngokuhambisana nemithi ethile (njengezidakamizwa ezithwala igazi kanye nama-anti-inflammatory agents) kungabangela imiphumela eyingozi.
Kubalulekile ukubonana nodokotela wakho ngaphambi kokusebenzisa ama-rose we-hip supplement.
Izindleko azange zihlolwe ukuphepha futhi ngenxa yokuthi izithako zokudla ngokuvamile azihambisani nomthetho, okuqukethwe kwemikhiqizo ethile kungase kuhluke kulokho okushiwo kwilebula lomkhiqizo.
Futhi khumbula ukuthi ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo ayisungulwa. Ungathola amathiphu engeziwe okusebenzisa izithako lapha .
Usebenzisa iRose Hip yezeMpilo
Nakuba kungekudala ukutusa i-hip rose nganoma yiziphi izinjongo ezihlobene nempilo, kungenzeka ukuthi ukwandisa ukudla kwakho (ngokuphuza i-herbal teas, isibonelo) kungase kuzuze impilo yakho.
Uma ucabangela ukusetshenziswa kwezithako ze-rose hip ekwelapheni inkinga ethile yempilo, khuluma nodokotela wakho ngaphambi kokuqala uhlelo lwakho lokubuyisela. Kubalulekile ukuqaphela ukuthi ukuzitholela isimo esingapheli nge-hip rose futhi ukugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi.
> Imithombo:
> Andersson U, Berger K, Högberg A, Landin-Olsson M, Holm C. "Imiphumela ye-Rose Hip Intake Emakhonini Abungozi Ohlobo Lwesifo Sikashukela Nesifo Sezinhliziyo: I-Randomized, Double Blind, Investigation Cross-Over in Abantu Abakhulu. "I-Eur J Clin Nutriti. 2011 Ngomhla ka-14, 2012: kufanele: 10.1038 / ejcn.2011.203.
> Andersson U, uHenriksson E, Ström K, Alenfall J, Göransson O, Holm C. "U-Rose Hip Usebenzisa Imiphumela Yesi-Antidiabetic Ngendlela Efaka Ukunciphisa Uhlelo Lwe-Lipogenic Hepatic." Am J Physiol Endocrinol Metab. 2011 Jan; 300 ( > 1): E111-21 >.
> Chrubasik C, Duke RK, Chrubasik S. "Ubufakazi bokusebenza koMtholampilo kaRose Hip and Seed: Ukubuyekezwa Okuhlelekile." I-Phytother Res. 2006 Jan; 20 (1): 1-3.
> Chrubasik C, Roufogalis BD, uMüller-Ladner U, Chrubasik S. "Ukubuyekezwa Okuhlelekile Kwamaphrofayli E-Effected and Efficiency Rosa Canina." I-Phytother Res. 2008 Jun; 22 (6): 725-33.
> U-Willich SN, Rossnagel K, Roll S, Wagner A, Mune O, > Erlendson > J, Kharazmi A, Sörensen H, Winther K. "Rose Hip Herbal Isixazululo Esigulini Esinezifo Ezibizwa Nge-Arthritis - I-Rheumatoid Controled Trial." I-Phytomedicine. 2010 Feb; 17 (2): 87-93.
> Winther K, Apel K, Thamsborg G. "Umfutho Owenziwe Ngembewu kanye Nezikhwama ze-Rose-Hip Subspecies (i-Rosa Canina) Iyanciphisa Izimpawu Zezintambo Ne-Hip Osteoarthritis: Isivivinyo Sengqondo Esilawulwa Ngama-Double-Blind, Esibanjwe Ngendawo. "Scand J Rheumatol. 2005 Jul-Aug; 34 (4): 302-8.